Trillium Asset Management LLC Invests $21.92 Million in Danaher Corporation $DHR

Key Points

• Trillium Asset Management acquired 30,443 Danaher shares worth approximately $21.92 million in the second quarter. Institutional investors and hedge funds collectively own 79.05% of Danaher’s stock.
• Analysts maintain a generally positive view, with Danaher receiving a consensus “Moderate Buy” rating and an average price target of $228.91, despite several recent target-price reductions.
• Danaher reported quarterly EPS of $1.94, beating estimates of $1.85, while revenue reached $6.26 billion and rose 5.5% year over year. Shares opened at $216.14, up 2.2%.

Trillium Asset Management LLC bought a new stake in Danaher Corporation (NYSE:DHR - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 30,443 shares of the conglomerate's stock, valued at approximately $21,923,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. Meeder Asset Management Inc. acquired a new stake in Danaher in the second quarter valued at about $44,000. MidFirst Bank acquired a new position in Danaher during the 2nd quarter worth approximately $46,000. Bell Investment Advisors Inc purchased a new position in shares of Danaher during the 2nd quarter worth approximately $47,000. State of Wyoming purchased a new position in shares of Danaher during the 2nd quarter worth approximately $74,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in shares of Danaher in the 4th quarter valued at approximately $27,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms recently weighed in on DHR. Weiss Ratings upgraded Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Wednesday, July 15th. Guggenheim reduced their target price on Danaher from $235.00 to $200.00 and set a "buy" rating for the company in a report on Wednesday, July 22nd. Evercore restated an "outperform" rating and set a $230.00 target price on shares of Danaher in a research report on Monday, July 6th. HSBC lowered their price target on shares of Danaher from $270.00 to $230.00 and set a "buy" rating on the stock in a research note on Wednesday, June 3rd. Finally, Piper Sandler began coverage on shares of Danaher in a report on Thursday, June 11th. They issued a "neutral" rating and a $200.00 price target for the company. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $228.91.

Danaher Trading Up 2.2%

NYSE:DHR opened at $216.14 on Friday. The company has a market capitalization of $151.94 billion, a PE ratio of 38.39, a price-to-earnings-growth ratio of 2.63 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The stock has a fifty day simple moving average of $195.01 and a 200-day simple moving average of $192.43.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to analysts' expectations of $6.12 billion. During the same period in the prior year, the company earned $0.77 EPS. The firm's revenue was up 5.5% on a year-over-year basis. On average, equities research analysts expect that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source